Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

This study has been completed.
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184223
First received: September 13, 2005
Last updated: June 3, 2016
Last verified: May 2016
  Purpose
The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.

Condition Intervention
Substance-Related Disorders
Behavioral: Motivational Interviewing
Other: Treatment as usual

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
Official Title: Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Substance use and function questionnaire [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Admissions to hospital [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Number of contacts with primary ealth care [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Enrollment: 135
Study Start Date: October 2004
Study Completion Date: June 2005
Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: motivational interviewing
Manual guided motivational interviewing in addition to treatment as usual
Behavioral: Motivational Interviewing
2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.
Other: Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.
control group
treatment as usual
Other: Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.

Detailed Description:

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone.

Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • substance use
  • acutely admitted to psychiatric hospital

Exclusion Criteria:

  • dementia
  • serious brain damage
  • not speaking Norwegian or English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184223

Locations
Norway
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Principal Investigator: Gunnar Morken, MD PhD Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184223     History of Changes
Other Study ID Numbers: GB-MI-2004 
Study First Received: September 13, 2005
Last Updated: June 3, 2016
Health Authority: Norway: Norwegian Social Science Data Services
Norway:National Committee for Medical and Health Research Ethics
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by Norwegian University of Science and Technology:
Motivational Interviewing
Substance abuse
Acuteley admitted psychiatric patients
Emergency Services, Psychiatric

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 28, 2016